The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
Open accessAbstract
Erythropoietin (EPO), originally identified for its critical hormonal role in promoting erythrocyte survival and differentiation, is a member of the large and diverse cytokine superfamily. Recent studies have identified multiple paracrine/autocrine functions of EPO that coordinate local responses to injury by maintaining vascular autoregulation and attenuating both primary (apoptotic) and secondary (inflammatory) causes of cell death. Experimental evidence also supports a role for EPO in repair and regeneration after brain and spinal cord injury, including the recruitment of stem cells into the region of damage. Tissue expression of the EPO receptor is widespread, especially during development, and includes the heart. However, it is currently unknown as to whether EPO plays a physiological function in adult myocardial tissue. We have assessed the potential protective role of EPO in vitro with adult rat cardiomyocytes, and in vivo in a rat model of myocardial infarction with reperfusion. The results show that EPO markedly prevents the apoptosis of cultured adult rat myocardiocytes subjected to 28 h of hypoxia (≈3% normal oxygen). Additional studies employing a rat model of coronary ischemia–reperfusion showed that the administration of recombinant human EPO (5,000 units/kg of body weight; i.p. daily for 7 days) reduces cardiomyocyte loss by ≈50%, an extent sufficient to normalize hemodynamic function within 1 week after reperfusion. These observations not only suggest a potential therapeutic role for recombinant human EPO in the treatment of myocardial ischemia and infarction by preventing apoptosis and attenuating postinfarct deterioration in hemodynamic function, but also predict that EPO is likely a tissue-protective cytokine in other organs as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
Gottlieb, R. A., Burleson, K. O., Kloner, R. A., Babior, B. M., & Engler, R. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117504 · Cited by 1,441
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Self-citationErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028
Self-citationErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Self-citationBlood Transfusion in Elderly Patients with Acute Myocardial Infarction
Wu, W.-C., Rathore, S. S., Wang, Y., Radford, M. J., & Krumholz, H. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010615 · Cited by 952
Digicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923
A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T., & Petit, E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00007 · Cited by 715
Matsui, T., Tao, J., del Monte, F., Lee, K.-H., Li, L., Picard, M., Force, T. L., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (2001) · Circulation · doi:10.1161/01.cir.104.3.330 · Cited by 701
Shingo, T., Sorokan, S. T., Shimazaki, T., & Weiss, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09733.2001 · Cited by 653
Silverberg, D. S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., Schwartz, D., Yachnin, T., Steinbruch, S., Shapira, I., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01248-7 · Cited by 644
Stretch-induced programmed myocyte cell death.
Cheng, W., Li, B., Kajstura, J., Li, P., Wolin, M. S., Sonnenblick, E. H., Hintze, T. H., Olivetti, G., & Anversa, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118280 · Cited by 640
Self-citationJonassen, A. K., Sack, M. N., Mjøs, O. D., & Yellon, D. M. (2001) · Circulation Research · doi:10.1161/hh2401.101385 · Cited by 523
Progressive ventricular remodeling in rat with myocardial infarction
Pfeffer, J. M., Pfeffer, M. A., Fletcher, P. J., & Braunwald, E. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.5.h1406 · Cited by 500
Celik, M., Gökmen, N., Erbayraktar, S., Akhisaroglu, M., Konakç, S., Ulukus, C., Genc, S., Genc, K., Sagiroglu, E., Cerami, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042693799 · Cited by 473
Self-citationLeri, A., Claudio, P. P., Li, Q., Wang, X., Reiss, K., Wang, S., Malhotra, A., Kajstura, J., & Anversa, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci316 · Cited by 456
Self-citationErythropoietin receptor signalling is required for normal brain development
Yu, X., Shacka, J. J., Eells, J. B., Suarez-Quian, C., Przygodzki, R. M., Beleslin-Cokic, B., Lin, C.-S., Nikodem, V. M., Hempstead, B., Flanders, K. C., et al. (2002) · Development · doi:10.1242/dev.129.2.505 · Cited by 367
Erythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous System
Juul, S. E., Anderson, D. K., Li, Y., & Christensen, R. D. (1998) · Pediatric Research · doi:10.1203/00006450-199801000-00007 · Cited by 359
Inactivation of erythropoietin leads to defects in cardiac morphogenesis
Wu, H., Lee, S. H., Gao, J., Liu, X., & Iruela-Arispe, M. L. (1999) · Development · doi:10.1242/dev.126.16.3597 · Cited by 349
Olivetti, G., Capasso, J. M., Sonnenblick, E. H., & Anversa, P. (1990) · Circulation Research · doi:10.1161/01.res.67.1.23 · Cited by 344
Self-citationAgnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M. L., & Ghezzi, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03239-0 · Cited by 334
Self-citationErythropoietin and VEGF Exhibit Equal Angiogenic Potential
Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S., & Kuck, K.-H. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2426 · Cited by 317
Hyperglycemia Activates p53 and p53-Regulated Genes Leading to Myocyte Cell Death
Fiordaliso, F., Leri, A., Cesselli, D., Limana, F., Safai, B., Nadal-Ginard, B., Anversa, P., & Kajstura, J. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2363 · Cited by 307
Self-citationSadamoto, Y., Igase, K., Sakanaka, M., Sato, K., Otsuka, H., Sakaki, S., Masuda, S., & Sasaki, R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9748 · Cited by 304
Apoptosis and myocardial infarction
Anversa, P., Cheng, W., Liu, Y., Leri, A., Redaelli, G., & Kajstura, J. (1998) · Basic Research in Cardiology · doi:10.1007/s003950050195 · Cited by 274
Self-citationErythropoietin Stimulates Proliferation and Interferes with Differentiation of Myoblasts
Ogilvie, M., Yu, X., Nicolas-Metral, V., Pulido, S. M., Liu, C., Ruegg, U. T., & Noguchi, C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004999200 · Cited by 262
Angiotensin II Activates Programmed Myocyte Cell Deathin Vitro
Cigola, E., Kajstura, J., Li, B., Meggs, L. G., & Anversa, P. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3477 · Cited by 209
Self-citationSugawa, M., Sakurai, Y., Ishikawa-Ieda, Y., Suzuki, H., & Asou, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00161-x · Cited by 197
Grasso, G., Buemi, M., Alafaci, C., Sfacteria, A., Passalacqua, M., Sturiale, A., Calapai, G., De Vico, G., Piedimonte, G., Salpietro, F. M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082097299 · Cited by 178
Nuclear Factor-κB Is Selectively and Markedly Activated in Humans With Unstable Angina Pectoris
Ritchie, M. E. (1998) · Circulation · doi:10.1161/01.cir.98.17.1707 · Cited by 174
Nandagopal, K., Dawson, T. M., & Dawson, V. L. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29559-8 · Cited by 171
Nonanticoagulant heparin inhibits NF-κB activation and attenuates myocardial reperfusion injury
Thourani, V. H., Brar, S. S., Kennedy, T. P., Thornton, L. R., Watts, J. A., Ronson, R. S., Zhao, Z.-Q., Sturrock, A., Hoidal, J. R., & Vinten‐Johansen, J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h2084 · Cited by 83
Squadrito, F., Altavilla, D., Squadrito, G., Campo, G. M., Arlotta, M., Quartarone, C., Saitta, A., & Caputi, A. P. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702521 · Cited by 72
Erythropoietin‐induced excessive erythrocytosis activates the tissue endothelin system in mice
Quaschning, T., Ruschitzka, F. T., Stallmach, T., Shaw, S., Morawietz, H., Göettsch, W., Hermann, M., Slowinski, T., Theuring, F., Hocher, B., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0296fje · Cited by 72
Masuda, S., Nagao, M., & Sasaki, R. (1999) · PubMed · Cited by 71
Mitogenic effect of erythropoietin on neonatal rat cardiomyocytes: Signal transduction pathways
Wald, M. R., Borda, E., & Sterin‐Borda, L. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199606)167:3<461::aid-jcp10>3.0.co;2-7 · Cited by 69
Erythropoietin in the control of red cell production
JELKMANN, W. E. B., & Metzen, E. (1996) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(96)80124-5 · Cited by 66
Cellular basis of ventricular remodeling after myocardial infarction in rats.
Olivetti, G., Quaini, F., Lagrasta, C. A. M., Cigola, E., Ricci, R., Maestri, R., & Anversa, P. (1995) · PubMed · Cited by 15
Self-citation
Cited by
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028
Update on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026
“Similarly, erythropoietin, used extensively in humans for stimulating erythropoiesis, also has prominent antiapoptotic and antiinflammatory actions (179) and has been used successfully for functional amelioration of ischemic AKI in animals (65,77,180).”
BackgroundOxygen Sensing, Homeostasis, and Disease
Semenza, G. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011165 · Cited by 993
Wang, L., Zhang, Z., Wang, Y., Zhang, R., & Chopp, M. (2004) · Stroke · doi:10.1161/01.str.0000132196.49028.a4 · Cited by 763
Heart failure and kidney dysfunction: epidemiology, mechanisms and management
Schefold, J. C., Filippatos, G., Hasenfuss, G., Anker, S. D., & von Haehling, S. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.113 · Cited by 671
Metadata
- Authors
- Calvillo, L., Latini, R., Kajstura, J., Leri, A., Anversa, P., Ghezzi, P., Salio, M., Cerami, A., & Brines, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-03-27
- Volume
- 100
- Issue
- 8
- Pages
- 4802-4806
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2058141781
- Cited by
- 611
- References
- 38
- FWCI
- 23.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.